House of HR - comment - 26Q3

House of HR performed right on target in Q326, showing further growth in its STS business, while E&C continues to go sideways, or slightly negative on the top line, with good cost control, delivering flat EBITDA growth vs. last year. On an adjusted EBITDA basis, therefore, the company outperformed our expectations by an encouraging €2.5m. 

Even more encouraging is a continued improvement in E&C PAW, gradually closing the gap to prior, more efficient years, and the Care Ratio has now reached peak 2022 levels again. 
If we assume the outperformance is therefore here to stay, our curves predict a 1.1-1.2x normalised FCCR in 2027 (excl. catch-up taxes). Not great, but possibly fair to start negotiating with the RCF, which goes current 5 months later while significantly drawn.

Wolfgang FelixHOUSE OF HR